Hamden, Connecticut – Vanessa Research Inc. (VRI), has announced the launch of a new educational video (link) on microvillus inclusion disease (MVID) – a rare, genetic intestinal disease that causes severe diarrhea in young babies, and it is resistant to treatment. The loss of fluids is so rapid that life-threatening dehydration occurs within days or...

February 9, 2018 Hamden, Connecticut - Vanessa Research (VRI), a New Haven based research and development company, has announced it will be supporting Rare Disease Day 2018 at Quinnipiac University. Dr. Dmitry Kravtsov, VP of Research and Development for VRI will be one of two presenters at the University’s North Haven Campus on February 27th, 2018...

October 6th, 2017 By Helen O’Callaghan - This article originally published on Irish Examiner Ronald McDonald House is a gift to parents, writes Helen O’Callaghan. Eileen and Anna Kenny help Taoiseach Leo Varadkar launch Ronald McDonald House Charity’s appeal. When the phone rings to say there’s a room free in Ronald McDonald House, it’s like winning the lotto,...

September 15, 2017 Hamden, Connecticut - Vanessa Research, Inc. (VRI), has announced the launch of a new educational website on microvillus inclusion disease or MVID – a rare, lethal genetic disorder that causes severe and chronic diarrhea in young babies and children. The goal of the site is to share resources with families and patients living with the daily...

July 31, 2017 We have taken many steps this summer to getting Shylicine approved for use in treating microvillus inclusion disease, a rare pediatric disorder that causes chronic diarrhea. Our goal with this oral anti-diarrheal treatment is to restore intestinal function so patients can eat and drink normally. In June, we received a patent from...